Mitsubishi UFJ Trust & Banking’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.4M Buy
86,402
+12,269
+17% +$3.06M 0.05% 340
2025
Q4
$17.9M Buy
74,133
+354
+0.5% +$90.5K 0.04% 369
2025
Q3
$20.2M Sell
73,779
-2,805
-4% -$766K 0.04% 388
2025
Q2
$19.8M Sell
76,584
-34,713
-31% -$8.28M 0.05% 379
2025
Q1
$24.9M Sell
111,297
-154
-0.1% -$36K 0.06% 310
2024
Q4
$25.5M Buy
111,451
+23,250
+26% +$5.6M 0.06% 321
2024
Q3
$21.5M Buy
88,201
+2,712
+3% +$606K 0.05% 373
2024
Q2
$16.4M Sell
85,489
-10,649
-11% -$2.16M 0.04% 430
2024
Q1
$19M Sell
96,138
-3,135
-3% -$574K 0.04% 409
2023
Q4
$17.1M Sell
99,273
-16,828
-14% -$2.59M 0.04% 430
2023
Q3
$17.2M Sell
116,101
-2,110
-2% -$382K 0.04% 410
2023
Q2
$25.8M Sell
118,211
-333
-0.3% -$74.2K 0.06% 335
2023
Q1
$26M Buy
118,544
+1,535
+1% +$333K 0.06% 323
2022
Q4
$24.4M Buy
117,009
+1,239
+1% +$272K 0.06% 330
2022
Q3
$25.3M Sell
115,770
-163
-0.1% -$37.1K 0.07% 303
2022
Q2
$24.3M Sell
115,933
-2,955
-2% -$629K 0.06% 323
2022
Q1
$28.8M Sell
118,888
-5,352
-4% -$1.29M 0.07% 301
2021
Q4
$32.4M Sell
124,240
-197,255
-61% -$51.2M 0.07% 304
2021
Q3
$84.7M Sell
321,495
-11,500
-3% -$3.14M 0.18% 136
2021
Q2
$82.1M Sell
332,995
-5,426
-2% -$1.14M 0.17% 145
2021
Q1
$65.7M Sell
338,421
-28,719
-8% -$5.76M 0.14% 172
2020
Q4
$78M Buy
367,140
+4,017
+1% +$801K 0.16% 159
2020
Q3
$62.3M Sell
363,123
-90,464
-20% -$16.7M 0.14% 175
2020
Q2
$87.1M Buy
453,587
+39,240
+9% +$6.42M 0.21% 113
2020
Q1
$61M Buy
414,347
+5,304
+1% +$845K 0.18% 131
2019
Q4
$63.4M Sell
409,043
-18,175
-4% -$2.62M 0.15% 144
2019
Q3
$57.1M Buy
427,218
+13,232
+3% +$1.73M 0.15% 154
2019
Q2
$49.9M Buy
413,986
+54,273
+15% +$6.01M 0.17% 126
2019
Q1
$36.9M Sell
359,713
-16,996
-5% -$1.75M 0.14% 177
2018
Q4
$42.9M Sell
376,709
-6,022
-2% -$645K 0.18% 129
2018
Q3
$44.1M Sell
382,731
-175,007
-31% -$19.2M 0.16% 153
2018
Q2
$57.8M Sell
557,738
-7,256
-1% -$734K 0.1% 233
2018
Q1
$55.6M Buy
564,994
+14,671
+3% +$1.39M 0.1% 234
2017
Q4
$46.6M Buy
550,323
+29,795
+6% +$2.46M 0.08% 275
2017
Q3
$40.1M Buy
520,528
+1,709
+0.3% +$131K 0.07% 306
2017
Q2
$40.4M Buy
518,819
+955
+0.2% +$68.3K 0.08% 291
2017
Q1
$37.3M Sell
517,864
-4,031
-0.8% -$279K 0.07% 305
2016
Q4
$32.4M Sell
521,895
-3,702
-0.7% -$227K 0.07% 329
2016
Q3
$34.1M Buy
525,597
+240,393
+84% +$16M 0.07% 322
2016
Q2
$18M Buy
285,204
+2,623
+0.9% +$155K 0.04% 484
2016
Q1
$16.3M Buy
282,581
+3,021
+1% +$171K 0.04% 516
2015
Q4
$15M Buy
279,560
+16,577
+6% +$934K 0.03% 526
2015
Q3
$13.4M Sell
262,983
-2,376
-0.9% -$128K 0.03% 549
2015
Q2
$15M Buy
265,359
+2,720
+1% +$172K 0.03% 546
2015
Q1
$18.9M Buy
262,639
+3,318
+1% +$216K 0.04% 472
2014
Q4
$14.5M Buy
259,321
+2,414
+0.9% +$126K 0.03% 538
2014
Q3
$12.7M Sell
256,907
-68,696
-21% -$3.5M 0.03% 553
2014
Q2
$16.5M Buy
325,603
+12,348
+4% +$612K 0.04% 496
2014
Q1
$14M Sell
313,255
-22,569
-7% -$1.01M 0.03% 523
2013
Q4
$15.8M Sell
335,824
-9,410
-3% -$476K 0.04% 495
2013
Q3
$18.2M Buy
345,234
+78,969
+30% +$3.83M 0.05% 431
2013
Q2
$12M Buy
+266,265
New +$12.6M 0.03% 527

Other funds holding RMD

Mitsubishi UFJ Trust & Banking's RMD Position: Q1 2026 in Review

Mitsubishi UFJ Trust & Banking increased its ResMed (RMD) stake by 17% in Q1 2026, buying an estimated $3.06M and bringing the position to 86,402 shares worth $19.4M. The position accounts for 0.05% of the portfolio, ranked #340.

Mitsubishi UFJ Trust & Banking first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $87.1M in Q2 2020. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Mitsubishi UFJ Trust & Banking held 86,402 shares of ResMed worth $19.4M as of Q1 2026.
  • Mitsubishi UFJ Trust & Banking bought 12,269 ResMed shares in Q1 2026, an estimated $3.06M.
  • ResMed made up 0.05% of Mitsubishi UFJ Trust & Banking's portfolio in Q1 2026, its #340 holding.
  • Mitsubishi UFJ Trust & Banking first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
  • Mitsubishi UFJ Trust & Banking's ResMed position peaked at $87.1M in Q2 2020.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q1 2026, filed 12 May 2026.